Navigation Links
Hemaclear Announces First Annual Italian Distributor and User Conference: May 22, 2013 in Rome, Italy
Date:5/15/2013

Haifa, Israel (PRWEB) May 15, 2013

OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it will hold its first annual Italian distributor and user conference; May 22, 2013 in Rome, Italy. The conference will be the first time Hemaclear users and distributors from Italy will meet to discuss the competitive and clinical advantage of the novel tourniquet.

Since the launch of Hemaclear in 2008 in Italy, the novel tourniquet has quickly become the standard of care at many Italian hospitals and clinics. Over the past 5 years regional distributors have recognized the positive business contributions of the device, while surgeons have recognized the positive clinical contributions. In a country where reusable pneumatic tourniquets were the standard of care prior to the launch of Hemaclear, physicians and patients can now experience the benefits of a reliable, safe, and sterile tourniquet.

“We are very excited to have the opportunity to meet with our distributor partners and surgeon users in Rome. This conference will provide all an opportunity to learn, network, and further discuss our commercialization efforts in Italy,” said Omer Inbar, CEO, OHK Medical Devices. Mr. Inbar added, “After a very strong year in 2012, we hope to continue the positive momentum in Italy. We strive to increase our Italian distribution network, and surgeon user base.”

OHK Medical Devices will be hosting the meeting May 22, 2013 at the Sofitel Rome Villa Borghese. To schedule a meeting or learn more about the conference please email info(at)hemaclear(dot)com.

About HemaClear®

HemaClear® is the world’s leading sterile tourniquet with a simple yet innovative technology, representing a new standard of care in bloodless orthopedic surgery. Since entering the market in 2007 this product has been successfully used in almost 500,000 procedures. Easier, cheaper and safer than the standard offerings, HemaClear® represents the first significant advancement in tourniquet technology in over 100 years. HemaClear® was developed by OHK Medical Devices (OHK), a privately held company based in Haifa, Israel and the United States and is currently used in over 2000 operating rooms across 30 countries. For more information about HemaClear®, visit http://www.hemaclear.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10735331.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. HemaClear Launches Activity in APAC
2. IntraMed Diagnostics Announces Two Senior-Level Additions
3. Omeros Announces Closing of $16.2 Million Registered Direct Offering of Common Stock
4. Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
5. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
6. Winding River Productions Announces High-End Studio Enhancements Including SCORM-Compliant e-Learning Media Development and On-Location Data and Media Capture Platforms
7. Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare Conference
8. Yongye International Announces First Quarter 2013 Financial Results
9. Vestiage Announces Initial Advisory Board Members
10. PDL BioPharma Announces First Quarter 2013 Financial Results
11. Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016 ... (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD ... (Academics Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, ... MarketsandMarkets, the market is expected to reach ... 7.63 Billion in 2015, growing at a ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... accessibility to unique bioresearch materials from laboratories across the globe, today announced the ... to increase the pace of research toward treatment and prevention measures for the ...
(Date:5/3/2016)... ... May 03, 2016 , ... Nashville Fertility Center ... A contingency of reproductive endocrinologists, including Dr. George Hill at Nashville ... to help them build families. , Ovation Fertility is a nationwide network of ...
(Date:4/29/2016)... Italy (PRWEB) , ... April 30, 2016 , ... The ... extraordinary textile design, the bioLogic team explored how bacterial properties can be applied to ... of using Natto bacteria, which move in response to humidity change. The team harvested ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
Breaking Biology News(10 mins):